Univest
Univest
  • Markets

Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III: NAV, Returns and Maturity Status Compared

  • July 21, 2026
  • Posted by: Kunal Singla
  • Category: News
No Comments
Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III

Sundaram Long Term Tax Advantage Fund Series II NAV Rs 36.3216, 13.76% CAGR since 2016. UTI Long Term Advantage Fund Series matured, final NAV Rs 23.2926, lifetime CAGR 16.62%.

Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III compares two schemes that have both already matured. Sundaram Long Term Tax Advantage Fund Series II closed at a final NAV of Rs 36.3216 in 2026, while the comparison fund closed at Rs 23.2926 in 2021, and neither is available for fresh investment today.

That difference shapes what Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III means for you. If you hold units in either scheme, the lock in period has ended, so the choice is between redeeming now, holding until maturity, or reallocating toward an open ended ELSS fund that accepts fresh money and runs a SIP.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III: Quick Comparison Table
  • Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III: NAV and Live Performance
  • Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III: Maturity and Investment Status
  • Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III: Which Fund Performed Better
  • Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III: Key Takeaways for Tax Saving Investors
  • Conclusion
  • FAQs on Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III
    • In Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III, which fund performed better?
    • What is the latest NAV of Sundaram Long Term Tax Advantage Fund Series II in Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III?
    • Is the comparison fund in Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III still active?
    • Can I invest in either fund from Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III today?
    • What type of fund is Sundaram Long Term Tax Advantage Fund Series II?
    • What returns has Sundaram Long Term Tax Advantage Fund Series II delivered?
    • What happened to investors in the Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III comparison at maturity?
    • What is the key takeaway from Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III?

Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III: Quick Comparison Table

The table below sets out Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III on structure, NAV and verified returns computed from official AMFI NAV history.

Parameter Sundaram Long Term Tax Advantage Fund Series II UTI Long Term Advantage Fund Series III
Fund house Sundaram Mutual Fund UTI Mutual Fund
Category Close ended ELSS Close ended ELSS
Units allotted 2016 2016
Current status Matured in 2026 Matured in 2021
Latest / final NAV Rs 36.3216 Rs 23.2926
CAGR since launch 13.76% per year 16.62% per year
Total return since launch About 262.9% About 132.4%
Lock in 3 years (already over) 3 years (already over)
Fresh investment allowed No, NFO only scheme No, NFO only scheme

Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III: NAV and Live Performance

The Sundaram Long Term Tax Advantage Fund Series II side of Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III has compounded investor money at 13.76 percent per year since units were allotted in 2016, a total gain of about 262.9 percent to date. Based on AMFI NAV history, it has also delivered a 3 year CAGR of 14.39 percent and a 5 year CAGR of 13.03 percent.

The comparison fund in Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III, UTI Long Term Advantage Fund Series III, has compounded at 16.62 percent per year since 2016, a total return of about 132.4 percent locked in at its final NAV.

Use the Univest Screener to Compare Live Fund and Stock Data

Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III: Maturity and Investment Status

Structurally, Sundaram Long Term Tax Advantage Fund Series II is a close ended ELSS. It accepted money only during its 2016 new fund offer, gave investors Section 80C tax benefits, and imposed a three year lock in. Since that lock in ended, unitholders have been free to redeem on any business day at NAV, and the scheme has since completed its full life cycle and matured.

The comparison fund in Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III followed the same structure. It has already completed its full life cycle, with outstanding units compulsorily redeemed at the prevailing NAV of Rs 23.2926 in 2021.

Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III: Which Fund Performed Better

On pure lifetime CAGR, Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III tilts toward UTI Long Term Advantage Fund Series III, which has compounded at 16.62 percent per year versus 13.76 percent per year for the other scheme. Entry and exit timing plays a real role here since ELSS NFOs launched in different market cycles naturally show different lifetime returns.

Total wealth created can tell a different story than annualised CAGR in Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III. A scheme that has stayed invested longer compounds a larger absolute gain even at a lower annual rate, while a matured scheme locks in its return the moment it closes and forces the investor to find a new home for that money, which carries its own reinvestment risk.

The honest verdict from Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III is that both schemes broadly did their job as Section 80C tax savers. Each one delivered a healthy multi year return well ahead of inflation. The bigger lesson from Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III sits in the close ended structure itself, not in which fund edged ahead.

Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III: Key Takeaways for Tax Saving Investors

Close ended ELSS schemes, as Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III shows, are largely a discontinued category today. You cannot add money after the NFO, you cannot run a SIP, and your exit at maturity may or may not land in a favourable market. Open ended ELSS funds solve all three problems while offering the same Section 80C benefit and the same three year lock in per instalment.

If you still hold either fund from Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III, review it the way you would any equity fund. The lock in is over on both sides, so the choice between redeeming now and holding until maturity should rest on your goals, your tax situation on gains, and whether the money has a better destination. A SEBI registered investment adviser can help you weigh that call against your full portfolio.

Many investors researching Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III also want to know how the lock in and tax treatment compare before deciding where to hold their money.

For a reader evaluating Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III, the NAV figures above are the fastest way to see which scheme has compounded faster to date.

Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III is a useful reference point whenever either scheme comes up in a broader ELSS portfolio review.

Anyone tracking Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III should note that neither scheme is open for new lump sum or SIP investment today.

The comparison in Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III is most useful for existing unitholders deciding whether to redeem, hold, or reinvest elsewhere.

Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III also matters for investors comparing Section 80C options across different fund houses before their next tax filing.

Download the Univest iOS App or Univest Android App to track funds, stocks and SEBI registered research in one place.

Conclusion

Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III ultimately does not favour one fund by a wide margin. Sundaram Long Term Tax Advantage Fund Series II shows a verified CAGR of 13.76 percent since 2016, while the comparison fund has compounded at 16.62 percent since 2016. Neither side of Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III accepts fresh money today, so for new tax saving investment in FY 2026-27, an open ended ELSS with a consistent track record is the practical route. Historically, disciplined ELSS investing has rewarded patience, but always consult a SEBI registered adviser before acting.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III

In Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III, which fund performed better?

Ans. On lifetime CAGR, UTI Long Term Advantage Fund Series III finished ahead at about 16.62 percent per year, versus 13.76 percent per year for the other scheme in this comparison. Total wealth created can still favour the scheme that has stayed invested longer, even at a lower annual rate.

What is the latest NAV of Sundaram Long Term Tax Advantage Fund Series II in Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III?

Ans. The final NAV of Sundaram Long Term Tax Advantage Fund Series II is Rs 36.3216, per official AMFI data, declared in 2026 at maturity.

Is the comparison fund in Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III still active?

Ans. No, it has already matured. Its final declared NAV was Rs 23.2926, declared in 2021, after which the scheme stopped publishing NAVs and proceeds were paid out to unitholders.

Can I invest in either fund from Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III today?

Ans. No fresh investment is possible in either scheme covered in Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III. Both are close ended ELSS schemes that accepted subscriptions only during their respective new fund offers, and neither is accepting or holding new investor money now.

What type of fund is Sundaram Long Term Tax Advantage Fund Series II?

Ans. Sundaram Long Term Tax Advantage Fund Series II is a close ended equity linked savings scheme, or ELSS, from Sundaram Mutual Fund. Investments made during its NFO qualified for Section 80C tax deduction and carried a three year lock in period.

What returns has Sundaram Long Term Tax Advantage Fund Series II delivered?

Ans. Sundaram Long Term Tax Advantage Fund Series II has compounded at roughly 13.76 percent per year since its 2016 launch, a total gain of about 262.9 percent, with a 3 year CAGR of 14.39 percent per the latest AMFI NAV history.

What happened to investors in the Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III comparison at maturity?

Ans. At maturity, outstanding units were compulsorily redeemed at the prevailing NAV and the proceeds were paid to unitholders. This is the standard process for every close ended ELSS scheme once its tenure ends.

What is the key takeaway from Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III?

Ans. The key takeaway from Sundaram Long Term Tax Advantage Fund Series II vs UTI Series III is that close ended ELSS schemes cannot take fresh money after their NFO, so investors comparing them today should treat this as a reference case rather than a live investment choice. An open ended ELSS fund with a consistent long term record is the practical route for new tax saving investment.



News
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply